Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in AYTU — Aytu Biopharma, Inc

CIK 1533421 NEW YORK, NY
Back to AYTU Full portfolio

Position in AYTU

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$4,798
+$529 QoQ
Shares Held
2,232
+42.7% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 38 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AYTU Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $14,082,412 across 58 Drug Manufacturers - Specialty & Generic names. AYTU ranks #49 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 111,351 $3,860,538
2 UTHR
UNITED THERAPEUTICS Corp
 3,880 $2,102,300
3 ZTS
Zoetis Inc.
 24,069 $1,729,598
4 NBIX
Neurocrine Biosciences Inc
 7,270 $1,225,285
5 ELAN
Elanco Animal Health Inc
 38,301 $942,587
6 LNTH
Lantheus Holdings, Inc.
 6,773 $751,395
7 ALKS
Alkermes plc.
 6,157 $322,626
8 INDV
Indivior Pharmaceuticals, Inc.
 7,032 $288,522

All Filings in AYTU

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,798 2,232
2026-03-31 $4,269 1,564
2025-12-31 $4,453 1,713
2025-09-30 $8,127 4,323
2025-06-30 $5,532 2,538
2025-03-31 $5,629 4,691
2024-12-31 $4,457 2,622
2024-09-30 $3,461 1,473
2024-06-30 $5,729 1,962
2024-03-31 $9,199 3,026
2023-12-31 $6,483 2,283
2023-09-30 $15,535 5,754
2023-06-30 $11,475 7,172
2023-03-31 $3,866 1,726
2022-12-31 $6,130 32,267
2022-09-30 $9,519 50,104
2022-06-30 $28,718 41,621
2022-03-31 $29,615 27,423
2021-12-31 $39,306 29,116
2021-09-30 $4,440 1,542
2021-06-30 $54,022 10,783
2021-03-31 $10,837 1,426
2020-12-31 $15,362 2,569
2020-09-30 $26,044 21,886
2020-06-30 $4,828 3,400